Financial Market – Insights on the Immunoassay Global Market to 2025
DUBLIN, March 3, 2021 /PRNewswire/ — The “Immunoassay Markets Strategies and Trends. Forecasts by Instrument Type and by Application and by Country. With Multiplex and Point of Care Market Analysis, Executive Guides and including Customized Forecasting and Analysis. 2021 to 2025” report has been added to ResearchAndMarkets.com’s offering.
The workhorse of the diagnostic industry is finding new legs. The pandemic has created a new demand for rapid easily available diagnostics. Immunoassay is stepping up. Advances in genetic knowledge are creating new markets for immunoassay. Rapid diagnostics, point of care, biomarkers and consumer markets are all areas of expansion while traditional immunoassay maintains a strong position in the growing market for clinical diagnostics. The publisher profiles 44 companies, large and small, working in this area.
Immunoassay Market – Strategic Situation Analysis & COVID Impact
Guide for Executives, Marketing, Sales and Business Development Staff
Guide for Management Consultants and Investment Advisors
Key Topics Covered:
1. Introduction and Market Definition
1.1 Immunoassay Markets Definition In This Report
1.1.1 Enzyme Based
1.1.2 Immunofluorescence
1.1.3 Chemiluminescence
1.1.4 DNA/NAT
1.1.5 RIA & Other
1.1.6 Reagents/Kits, Analyzers, Software & Services
1.1.7 Infectious Disease
1.1.8 Auto Immune
1.1.9 Endocrinology
1.1.10 Oncology
1.1.11 Cardiology
1.1.12 Other Specialty
1.2 Market Definition
1.2.1 Market Sizes
1.2.2 Currency
1.2.3 Years
1.3 Methodology
1.3.1 Authors
1.3.2 Sources
1.4 U.S. Medical Market and Clinical Laboratory Testing – Perspective
2. Industry Overview
2.1 Industry Participants
2.1.1 IVD Supplier
2.1.2 Independent lab specialized/esoteric
2.1.3 Independent lab national/regional
2.1.4 Independent lab analytical
2.1.5 Public National/regional lab
2.1.6 Hospital lab
2.1.7 Physician lab
2.1.8 Audit body
2.2 The Clinical Laboratory Market Segments
2.2.1 Traditional Market Segmentation
2.2.2 Laboratory Focus and Segmentation
2.2.3 Hospital Testing Share
2.2.4 Economies of Scale
2.2.4.1 Hospital vs. Central Lab
2.2.5 Physician Office Lab’s
2.2.6 Physician’s and POCT
2.3 Immunoassay -Markets and Discussion
2.3.1 Instruments – Genetics changes the picture
2.3.1.1 RIA – A Technology Shows its Age
2.3.1.2 Immunoassay vs. PCR vs. Sequencing – A See Saw Battle
2.3.1.3 The Smart Shrinking Instrument – Serious Implications
2.3.1.4 Research Funding and Capital Expense – Instrument Pooling
2.3.1.4 Multiplex vs. POC – A Tradeoff Analysis
2.3.2 Reagents and Kits – Genetics changes the picture
2.3.1.1 Bigger Test Menus a Boon for Kit Market
2.3.3 Physician Office Labs – A New Frontier
2.3.4 Rapid and POCT to Threaten Instrument Markets
2.3.5 OTC and DTC – Huge Market Potential
2.3.6 Economies of Scale. Going Away?
2.3.7 Lower Barriers to Entry for Instruments/Analyzers
2.3.8 Miniturization and Technology Drive Acquisition
3. Market Trends
3.1 Factors Driving Growth
3.1.1 Diagnostic Factors
3.1.2 Changing Technologies Spur Early Instrument Retirement.
3.1.3 Consumer Channels Open Wider
3.1.4 Immunity Technology Comes of Age
3.2 Factors Limiting Growth
3.2.1 Increased Competition Lowers price
3.2.2 Threat from PCR Based Instruments
3.2.3 Lower Barriers to Entry
3.2.4 Wellness has a downside
3.3 Immunoassay Instrumentation
3.3.1 Instrumentation Tenacity.
3.3.2 Declining Cost of Instruments Changes Industry Structure.
3.3.3 LISTING of CURRENT INSTRUMENT SPECIFICATIONS
3.3.4 Immunoassay – CRISPR Diagnostics
4. Immunoassay Recent Developments
4.1 Recent Developments – Importance and How to Use This Section
4.1.1 Importance of These Developments
4.1.2 How to Use This Section
COVID-19 Portfolio to Accelerate At-Home Infectious Disease Testing
Roche Diagnostics Expanding Testing Portfolio in 2021
PerkinElmer Long-Term Outlook
Quidel Updates Outlook for C19 Testing
Dx Companies Look at Multiplex Tests for SARS-CoV-2, Influenza
Becton Dickinson and NAT Diagnostics Acquisition
New test diagnoses Lyme disease within 15 minutes
Multiplexed Immunoassay System Differentiates Malaria Species
ER(BA) Mannheim Unveils Next-Generation Nexus unit
Uman Diagnostics And Bio-Techne Announce Agreement For Neurofilament Light Assay
Software reduces variability in ELISA biomarker tests
Arrayit Corporation Allergy Testing Network Doubles
Expedeon Signs License Deal With Cell Guidance Systems for Biotin Tech
Efficacy Investigated for Electrochemiluminescence Immunoassay
5. Profiles of Key Companies
Abbott Diagnostics
Abcam
Arlington Scientific
Arrayit Corporation
Awareness Technology
Beckman Coulter Diagnostics
Becton, Dickinson and Company
Biocartis
bioMerieux Diagnostics
Bioneer Corporation
Bio-Rad Laboratories, Inc
BioTek Instruments
Boditech Med, Inc
Boster Biological Technology
Diamedix (Erba Diagnostics)
Diasorin S.p.A
Dynex Technologies
Enzo Life Sciences, Inc
Eurofins Scientific
FUJIFILM Wako Diagnostics
Fujirebio
Gold Standard Diagnostics
Grifols
Hycor Biomedical
Immunodiagnostic Systems (IDS)
Immunodiagnostik AG
Inova Diagnostics
JR Biomedical
Luminex Corp
Maxim Biomedical
Meso Scale Discovery
Millipore Sigma
Mindray
Molecular Devices
MP Biomedical
MyCartis
Operon
Ortho Clinical Diagnostics
Perkin Elmer
Qiagen Gmbh
Quidel
R&D Systems
Randox Toxicology
Roche Molecular Diagnostics
Serametrix
Siemens Healthineers
Sysmex
Tecan
Thermo Fisher Scientific Inc
TOSOH Bioscience
6. The Global Market
6.1 Global Market by Country
6.1.1 Global Market by Country Table
6.1.2 Global Market by Country Chart
6.2 Global Market by Application
6.2.1 Global Market by Application Table
6.2.2 Global Market by Application Segment Growth Chart
6.2.3 Global Market by Application Segment Annual Chart
6.2.4 Global Market by Application Segment Base vs. Final
6.2.5 Global Market by Application Base Year
6.2.6 Global Market by Application Final Year
6.3 Global Market by Technology
6.3.1 Global Market by Technology Table
6.3.2 Global Market by Technology Segment Growth Chart
6.3.3 Global Market by Technology Segment Annual Chart
6.3.4 Global Market by Technology Segment Base vs. Final
6.3.5 Global Market by Technology Base Year
6.3.6 Global Market by Application Final Year
7. Global Market by Application
7.1 Endocrinology Applications
7.1.1 Endocrinology Applications by Country Table
7.1.2 Endocrinology Applications Growth Chart
7.2 Immune Applications
7.2.1 Immune Applications by Country Table
7.2.2 Immune Applications Growth Chart
7.3 Oncology Applications
7.3.1 Oncology Applications by Country Table
7.3.2 Oncology Applications Growth Chart
7.4 Infectious Disease Applications
7.4.1 Infectious Disease Applications by Country Table
7.4.2 Infectious Disease Applications Growth Chart
7.5 Cardiology Applications
7.5.1 Cardiology Applications by Country Table
7.5.2 Cardiology Applications Growth Chart
7.6 Other Applications
7.6.1 Other Applications by Country Table
7.6.2 Other Applications Growth Chart
8. Immunoassay by Technology
8.1 Enzyme
8.1.1 Enzyme by Country Table
8.1.2 Enzyme Growth Chart
8.2 Flourescence
8.2.1 Flourescence by Country Table
8.2.2 Flourescence Growth Chart
8.3 Chemiluminescence
8.3.1 Chemiluminescence by Country Table
8.3.2 Chemiluminescence Growth Chart
8.4 Nucleic Acid
8.4.1 Nucleic Acid by Country Table
8.4.2 Nucleic Acid Growth Chart
8.5 Rapid/POC
8.5.1 Rapid/POC by Country Table
8.5.2 Rapid/POC Growth Chart
8.6 Other Technology
8.6.1 Other Technology by Country Table
8.6.2 Other Technology Growth Chart
9. Vision of the Future of Immunoassay
For more information about this report visit https://www.researchandmarkets.com/r/vjmj6y
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected] For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Related Links http://www.researchandmarkets.com
Financial Market – Insights on the Immunoassay Global Market to 2025
